Molecular remission induced by gemtuzumab ozogamicin associated with donor lymphocyte infusions in t(4;11) acute lymphoblastic leukemia relapsed after transplantation

Leukemia. 2003 Nov;17(11):2247-8. doi: 10.1038/sj.leu.2403134.

Authors

Adriana Balduzzi, Vincenzo Rossi, Lilia Corral, Sonia Bonanomi, Daniela Longoni, Attilio Rovelli, Valentino Conter, Andrea Biondi, Cornelio Uderzo

PMID: 12960967
DOI: 10.1038/sj.leu.2403134

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antigens, CD / blood
Antigens, Differentiation, Myelomonocytic / blood
Chromosomes, Human, Pair 11*
Chromosomes, Human, Pair 4*
Histocompatibility Testing
Humans
Lymphocyte Transfusion*
Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics*
Precursor Cell Lymphoblastic Leukemia-Lymphoma / immunology
Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy
Recurrence
Sialic Acid Binding Ig-like Lectin 3
Stem Cell Transplantation*
Translocation, Genetic*

Substances

Antigens, CD
Antigens, Differentiation, Myelomonocytic
CD33 protein, human
Sialic Acid Binding Ig-like Lectin 3